About 256,000 results
Open links in new tab
  1. Home - MBX Biosciences

    MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

  2. MBX Biosciences, Inc. (MBX) - Yahoo Finance

    Find the latest MBX Biosciences, Inc. (MBX) stock quote, history, news and other vital information to help you with your stock trading and investing.

  3. MBX $31.97 ( 4.68%) MBX Biosciences Inc | Google Finance

    Get the latest MBX Biosciences Inc (MBX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  4. MBX Biosciences (MBX) Stock Price & Overview

    Nov 26, 2025 · A detailed overview of MBX Biosciences, Inc. (MBX) stock, including real-time price, chart, key statistics, news, and more.

  5. MBX Biosciences (MBX) Stock Price, News & Analysis - MarketBeat

    5 days ago · We are a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

  6. MBX Stock Price and Chart — NASDAQ:MBX — TradingView

    MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic …

  7. Do MBX Biosciences’ Phase 2 Win and Cash Raise Strengthen Its …

    5 days ago · In recent months, MBX Biosciences reported positive topline Phase 2 results for its lead candidate canvuparatide in hypoparathyroidism and completed an upsized US$200 …

  8. MBX Biosciences, Inc. Common Stock (MBX) - Nasdaq

    Oct 27, 2025 · Discover real-time MBX Biosciences, Inc. Common Stock (MBX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.

  9. MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and …

    5 days ago · In recent months, MBX Biosciences reported positive topline Phase 2 results for its lead drug canvuparatide in hypoparathyroidism and completed an upsized US$200,000,000 …

  10. MBX: MBX Biosciences Inc - Stock Price, Quote and News - CNBC

    Get MBX Biosciences Inc (MBX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.